IoT integration in the highly regulated Pharma environment

Giving a voice to physical assets 

Traditionally, pharmaceutical automation systems monitor process parameters such as temperature, pressure, flow, and level. While these variables are essential for controlling production, they provide limited visibility into the condition of the equipment itself.

This is where IoT introduces a new layer of intelligence. By deploying smart sensors alongside existing control systems, manufacturers can monitor asset-condition indicators such as vibration, acoustics, or product leakage, helping identify early signs of equipment degradation before failures occur. 

For Paulo, the real shift is moving from a reactive approach to a predictive mindset, where potential issues can be identified and addressed before they impact operations.  

“In simple terms, IoT integration is about giving a voice to physical assets.” -Paulo

Augmenting systems, not replacing them 

Paulo has seen firsthand how IoT technology is most effective when deployed alongside existing automation architectures. 

“Companies deploy IoT systems shoulder-to-shoulder with their traditional control systems,” he explains. “They are not replacing them; they are augmenting them.” 

For pharmaceutical manufacturers, this approach offers a practical path towards digitalisation. Rather than replacing validated systems, IoT can enhance existing assets with new capabilities such as condition monitoring and predictive maintenance. 

Take the continuous monitoring of agitators as an example. By analysing vibration patterns and detecting abnormal mechanical  behaviour, manufacturers can intervene before equipment failures affect production. 

“A predicted stoppage can really make a difference. If you identify a problem early enough, you can avoid losing a batch and prevent much bigger operational impacts further down the line.” 

Beyond protecting high-value batches, IoT integration can generate substantial cost savings for manufacturers. Access to real-time equipment data reduces the burden on maintenance teams, enables more effective planning, and helps organisations allocate manpower more efficiently rather than continually reacting to unexpected breakdowns.

Innovation within a GMP environment 

The opportunities presented by IoT are clear, but pharmaceutical manufacturing introduces challenges that are less common in other industries.

“The biggest challenge is that we work in a highly regulated environment.” 

Any new technology deployed within GMP operations must comply with strict validation requirements, data integrity principles, and industry frameworks such as GAMP 5. GAMP 5 (Good Automated Manufacturing Practice, 5^th Edition) is the rulebook for pharmaceutical automation.

It ensures that every automated system is rigorously tested and validated to protect patient safety. Since changes to a validated control system can trigger significant validation and compliance activities, manufacturers often deploy IoT solutions on separate, parallel networks rather than integrating them directly into GMP-critical systems. Even then, extensive change-control procedures must be completed before deployment. 

For Paulo, however, regulation should not be viewed as a barrier to innovation. Instead, it defines the framework within which innovation must operate. 

“There is still a huge opportunity for Pharma to embrace this approach. 
Other industries have already demonstrated the value that can be created when equipment data is used more effectively.” 

Why edge computing matters 

One of the biggest misconceptions around Industry 4.0 is that all manufacturing data should be sent directly to the cloud. However, “in high-speed manufacturing environments, that approach can create network congestion, latency, and security concerns,” Paulo explains. 

Instead, he advocates an edge-first approach, where data is filtered, cleaned, and analysed locally before only the most relevant information is transmitted to higher-level systems. 

---

“The value should first be created where the data is generated. You take baby steps before making the jump.” 

---

For manufacturers looking to scale IoT adoption, this approach can provide faster insights, reduce infrastructure demands, and help maintain greater control over industrial data flows.